News for hackers. Stuff that matters.
Re:Alzheimer’s Drug Sharply Slowed Cognitive Decline by bjwbell on Friday March 20, 2015 @05:24PM (#9240768)
TL;DR Phase 1 trial with 166 patients shows promise (many promising phase 1 trials don't pan out in phase 2 or 3 trials).
Re:Alzheimer’s Drug Sharply Slowed Cognitive Decline by WhitneyLand on Friday March 20, 2015 @06:30PM (#9241042)
It's got a ways to go for sure, but the exciting thing is this is the first drug ever to make it this far, with statistically significant reduction of plaques and cognitive decline.
Re:Alzheimer’s Drug Sharply Slowed Cognitive Decline by nhstanley on Saturday March 21, 2015 @04:59AM (#9242211)
This isn't the first antibody therapy that tries to reduce plaques (Bapineuzumab, solanezumab, gantenerumab, crenezumab, etc.), but is it the first one to "work" correctly, but still fail? I don't believe so. I think bapineuzumab also showed early promise at reducing plaques, though I don't remember if they did a cognitive analysis that Biogen did here.

Don't get me wrong. I think this is the most promising one we've had, if for no other reason than the method used to develop it. They took people who lived into old age without Alzheimer's, and found antibodies from them that targeted Abeta (so they claim). Really cool stuff, if true, and very promising.